2005
DOI: 10.1016/j.jconrel.2005.02.002
|View full text |Cite
|
Sign up to set email alerts
|

Biodegradable polymer microneedles: Fabrication, mechanics and transdermal drug delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

12
504
0
6

Year Published

2008
2008
2018
2018

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 802 publications
(522 citation statements)
references
References 27 publications
12
504
0
6
Order By: Relevance
“…This leaves the drug to diffuse across the viable skin (which consists of the viable epidermis and dermis) into the blood microcirculation. Assuming steady state transport across skin (Park et al, 2005), the effective permeability P eff of the skin when coated microneedles are being used is calculated by:…”
Section: Governing Equations For Drug Transport In Skin 165mentioning
confidence: 99%
“…This leaves the drug to diffuse across the viable skin (which consists of the viable epidermis and dermis) into the blood microcirculation. Assuming steady state transport across skin (Park et al, 2005), the effective permeability P eff of the skin when coated microneedles are being used is calculated by:…”
Section: Governing Equations For Drug Transport In Skin 165mentioning
confidence: 99%
“…Metals traditionally used for MN fabrication consist of stainless steel, nickel coated in gold, titanium, platinum and palladium (Martanto et al, 2004;Wang et al, 2006;Mansoor et al, 2013). Although numerous journal papers have been published on the use of silicon as a primary substituent of MN DOI: 10.3109/10717544.2014.986309 formulation, the material itself has yet to be FDA approved (Park et al, 2005).…”
Section: Trends In Mn Dd Methodsmentioning
confidence: 99%
“…They also differ in shape, ranging from square, circular, flat tipped, sharp tipped, etc. (Henry et al, 1998;Park et al, 2005;Gupta et al, 2009;Swain et al, 2011;Kommareddy et al, 2013;Mansoor et al, 2013;Torrisi et al, 2013;Pierre & Rossetti, 2014). There has been a lot of research conducted on MNs for the delivery and monitoring of various drugs such as glucose control for diabetics (Ito et al, 2006;Nordquist et al, 2007;Ainslie & Desai, 2008;El-Laboudi et al, 2013;Taylor & Sahota, 2013;Ita, 2014), Alzheimer's disease (Wei-Ze et al, 2010), anticancer (Fang et al, 2008) and other conditions (Ezan, 2013).…”
Section: Trends In Mn Dd Methodsmentioning
confidence: 99%
See 2 more Smart Citations